"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,GB,A,GB 2568684 A,005-106-380-040-335,2019-05-29,2019,GB 201719378 A,2017-11-22,GB 201719378 A,2017-11-22,Fire-fighting apparatus and method of fire-fighting,"A firefighting apparatus comprises a nozzle assembly 100 for protruding through a barrier or wall (not shown). The apparatus 100 broadly comprises a body 120, having at a proximal end 120a a handle 130 and at a distal end 120b a tip portion 140. In use, a conduit, such as a hose or lay flat hose (not shown) is coupled to the nozzle assembly 100 at the proximal end 120a, to connect to a supply of firefighting fluid, such as water, which fluid is conducted through the interior of the body 120 to the distal end 120b where it can be delivered to a fire. A sheath member 150, in the form of an axially sliding sleeve, is positioned on the body towards its distal end, at which it abuts the tip portion 140 in the configuration shown in the figure. An annular shield 160 is fixed to, and surrounds, the sleeve 150 at a location spaced from the distal end 120b. A method of firefighting using the apparatus is also disclosed.",F B FIRE TECH LTD,ABEL KAYOMB;;GARY TAYLOR,"EXWORKS CAPITAL FUND I, LP (2018-12-12)",https://lens.org/005-106-380-040-335,Patent Application,no,7,0,3,3,0,A62C31/05;;A62C31/22;;A62C31/03;;A62C31/22,A62C31/22;;A62C31/03,,0,0,,,,ACTIVE
2,GB,B,GB 2568684 B,166-644-903-458-586,2022-01-26,2022,GB 201719378 A,2017-11-22,GB 201719378 A,2017-11-22,Fire-fighting apparatus and method of fire-fighting,,F B FIRE TECH LTD,ABEL KAYOMB;;GARY TAYLOR,"EXWORKS CAPITAL FUND I, LP (2018-12-12)",https://lens.org/166-644-903-458-586,Granted Patent,no,7,0,3,3,0,A62C31/05;;A62C31/22;;A62C31/03;;A62C31/22,A62C31/22;;A62C31/03,,0,0,,,,ACTIVE
3,US,B2,US 9786010 B2,184-665-457-552-964,2017-10-10,2017,US 201414259676 A,2014-04-23,US 201414259676 A,2014-04-23,Homeowners insurance application process using geotagged photos,"Methods, systems, and computer readable media are disclosed for determining a homeowners insurance quote from a captured image of a dwelling. The captured image includes geotagged information, and the address of the dwelling is determined by reverse geocoding this information. An insurance premium quote may then be generated based on the reverse geocoded address and any additional risk assessment factors, such as the building characteristics. Verification of the address may also be performed by accessing one or more databases, which may store information including addresses, coordinates, and images associated with the address. The building characteristics may be retrieved from one or more of the databases to allow for quote generation with minimal user intervention. Matching properties having comparative quotes near the dwelling address may also be generated.",STATE FARM MUTUAL AUTOMOBILE INSURANCE CO,KIPER TIMOTHY;;TAYLOR DWAYNE;;ABEL JEFFREY HOWARD;;ENGELHORN AMY,STATE FARM MUTUAL AUTOMOBILE INSURANCE COMPANY (2014-04-08),https://lens.org/184-665-457-552-964,Granted Patent,yes,10,4,3,3,0,G06Q40/08;;G06Q30/0283;;G06Q40/08;;G06Q30/0283;;G06F16/2379;;G06F16/5866;;G06F16/29,G06Q40/08;;G06Q30/02,,0,0,,,,ACTIVE
4,US,A1,US 2015/0310556 A1,055-817-757-666-771,2015-10-29,2015,US 201414259676 A,2014-04-23,US 201414259676 A,2014-04-23,Homeowners Application Process Using Geotagged Photos,"Methods, systems, and computer readable media are disclosed for determining a homeowners insurance quote from a captured image of a dwelling. The captured image includes geotagged information, and the address of the dwelling is determined by reverse geocoding this information. An insurance premium quote may then be generated based on the reverse geocoded address and any additional risk assessment factors, such as the building characteristics. Verification of the address may also be performed by accessing one or more databases, which may store information including addresses, coordinates, and images associated with the address. The building characteristics may be retrieved from one or more of the databases to allow for quote generation with minimal user intervention. Matching properties having comparative quotes near the dwelling address may also be generated.",STATE FARM MUTUAL AUTOMOBILE INSURANCE CO,KIPER TIMOTHY;;TAYLOR DWAYNE;;ABEL JEFFREY HOWARD;;ENGELHORN AMY,STATE FARM MUTUAL AUTOMOBILE INSURANCE COMPANY (2014-04-08),https://lens.org/055-817-757-666-771,Patent Application,yes,2,17,3,3,0,G06Q40/08;;G06Q30/0283;;G06Q40/08;;G06Q30/0283;;G06F16/2379;;G06F16/5866;;G06F16/29,G06Q40/08;;G06Q30/02,,0,0,,,,ACTIVE
5,US,B1,US 10692151 B1,139-890-704-647-194,2020-06-23,2020,US 201715667318 A,2017-08-02,US 201715667318 A;;US 201414259676 A,2014-04-23,Homeowners insurance application process using geotagged photos,"Methods, systems, and computer readable media are disclosed for determining a homeowners insurance quote from a captured image of a dwelling. The captured image includes geotagged information, and the address of the dwelling is determined by reverse geocoding this information. An insurance premium quote may then be generated based on the reverse geocoded address and any additional risk assessment factors, such as the building characteristics. Verification of the address may also be performed by accessing one or more databases, which may store information including addresses, coordinates, and images associated with the address. The building characteristics may be retrieved from one or more of the databases to allow for quote generation with minimal user intervention. Matching properties having comparative quotes near the dwelling address may also be generated.",STATE FARM MUTUAL AUTOMOBILE INSURANCE CO,KIPER TIMOTHY;;TAYLOR DWAYNE;;ABEL JEFFREY HOWARD;;ENGELHORN AMY,STATE FARM MUTUAL AUTOMOBILE INSURANCE COMPANY (2014-04-08),https://lens.org/139-890-704-647-194,Granted Patent,yes,12,0,3,3,0,G06Q40/08;;G06Q30/0283;;G06Q40/08;;G06Q30/0283;;G06F16/2379;;G06F16/5866;;G06F16/29,G06Q40/08;;G06F16/23;;G06F16/29;;G06F16/58;;G06K9/62;;G06Q30/02,,6,1,016-852-502-994-297,pmc4590956;;10.1155/2014/567049;;26556417,"Ensuring Confidentiality of Geocoded Health Data: Assessing Geographic Masking Strategies for Individual Level Data (Year: 2014).;;U.S. Appl. No. 14/259,676, Final Office Action, dated May 26, 2015.;;U.S. Appl. No. 14/259,676, Final Office Action, dated Nov. 10, 2014.;;U.S. Appl. No. 14/259,676, Nonfinal Office Action, dated Jul. 17, 2014.;;U.S. Appl. No. 14/259,676, Nonfinal Office Action, dated Mar. 3, 2015.;;U.S. Appl. No. 14/259,676, Notice of Allowance, dated Jun. 22, 2017.",ACTIVE
6,WO,A2,WO 2006/118637 A2,067-067-233-102-575,2006-11-09,2006,US 2006/0006491 W,2006-02-24,US 11882105 A,2005-04-29,METHOD AND APPARATUS FOR SUPPLYING AIR TO EMISSION ABATEMENT DEVICE BY USE OF TURBOCHARGER,"An apparatus comprises a combustion engine, an emission abatement device, and a turbocharger. The emission abatement device is fluidly coupled to the engine to receive exhaust gas therefrom. The turbocharger comprises an air compressor that is fluidly coupled to the engine to supply pressurized air to the engine and that is fluidly coupled to the emission abatement device via a flow path not including any combustion section of the engine to supply pressurized air to the emission abatement device. An associated method is disclosed.",ARVIN TECHNOLOGIES INC;;TAYLOR WILLIAM;;KONG YOUGEN;;HUFFMEYER CHRISTOPHER;;KOZAKIEWICZ TOMASZ;;ABEL JOHN,TAYLOR WILLIAM;;KONG YOUGEN;;HUFFMEYER CHRISTOPHER;;KOZAKIEWICZ TOMASZ;;ABEL JOHN,,https://lens.org/067-067-233-102-575,Patent Application,yes,1,4,12,12,0,F02B37/00;;F02M23/12;;F02M23/12;;F01N3/025;;F01N3/025;;F01N3/035;;F01N3/035;;F01N3/0814;;F01N3/0814;;F01N3/0842;;F01N3/0842;;F01N3/106;;F01N3/106;;F01N3/2033;;F01N3/2033;;F01N3/2066;;F01N3/2066;;F01N3/22;;F01N3/22;;F01N3/32;;F01N3/32;;F01N3/326;;F01N3/326;;F01N5/04;;F01N13/009;;F01N13/009;;F01N2240/14;;F01N2240/14;;F01N2240/30;;F01N2240/30;;F01N2610/03;;F01N2610/03;;F02B37/166;;F02B37/166;;F02B37/168;;F02B37/168;;F02B39/00;;F02M27/02;;F02M27/02;;Y02T10/12;;Y02T10/12,F02M25/06;;F01N5/04;;F02B29/04,,1,0,,,See also references of EP 1888907A4,PENDING
7,WO,A3,WO 2006/118637 A3,119-136-429-744-255,2008-01-03,2008,US 2006/0006491 W,2006-02-24,US 11882105 A,2005-04-29,METHOD AND APPARATUS FOR SUPPLYING AIR TO EMISSION ABATEMENT DEVICE BY USE OF TURBOCHARGER,"An apparatus comprises a combustion engine, an emission abatement device, and a turbocharger. The emission abatement device is fluidly coupled to the engine to receive exhaust gas therefrom. The turbocharger comprises an air compressor that is fluidly coupled to the engine to supply pressurized air to the engine and that is fluidly coupled to the emission abatement device via a flow path not including any combustion section of the engine to supply pressurized air to the emission abatement device. An associated method is disclosed.",EMCON TECHNOLOGIES LLC;;TAYLOR WILLIAM;;KONG YOUGEN;;HUFFMEYER CHRISTOPHER;;KOZAKIEWICZ TOMASZ;;ABEL JOHN,TAYLOR WILLIAM;;KONG YOUGEN;;HUFFMEYER CHRISTOPHER;;KOZAKIEWICZ TOMASZ;;ABEL JOHN,,https://lens.org/119-136-429-744-255,Search Report,yes,6,0,12,12,0,F02B37/00;;F02M23/12;;F02M23/12;;F01N3/025;;F01N3/025;;F01N3/035;;F01N3/035;;F01N3/0814;;F01N3/0814;;F01N3/0842;;F01N3/0842;;F01N3/106;;F01N3/106;;F01N3/2033;;F01N3/2033;;F01N3/2066;;F01N3/2066;;F01N3/22;;F01N3/22;;F01N3/32;;F01N3/32;;F01N3/326;;F01N3/326;;F01N5/04;;F01N13/009;;F01N13/009;;F01N2240/14;;F01N2240/14;;F01N2240/30;;F01N2240/30;;F01N2610/03;;F01N2610/03;;F02B37/166;;F02B37/166;;F02B37/168;;F02B37/168;;F02B39/00;;F02M27/02;;F02M27/02;;Y02T10/12;;Y02T10/12,F01N5/04;;F01N3/00,,1,0,,,See also references of EP 1888907A4,PENDING
8,EP,B1,EP 1888907 B1,105-651-188-936-309,2016-04-13,2016,EP 06735952 A,2006-02-24,US 2006/0006491 W;;US 11882105 A,2005-04-29,METHOD AND APPARATUS FOR SUPPLYING AIR TO EMISSION ABATEMENT DEVICE BY USE OF TURBOCHARGER,,FAURECIA EMISSIONS CONTROL TECHNOLOGIES USA LLC,TAYLOR WILLIAM;;KONG YOUGEN;;HUFFMEYER CHRISTOPHER;;KOZAKIEWICZ TOMASZ;;ABEL JOHN,"FAURECIA EMISSIONS CONTROL TECHNOLOGIES, USA, LLC (2016-02-24)",https://lens.org/105-651-188-936-309,Granted Patent,yes,11,1,12,12,0,F02B37/00;;F02M23/12;;F02M23/12;;F01N3/025;;F01N3/025;;F01N3/035;;F01N3/035;;F01N3/0814;;F01N3/0814;;F01N3/0842;;F01N3/0842;;F01N3/106;;F01N3/106;;F01N3/2033;;F01N3/2033;;F01N3/2066;;F01N3/2066;;F01N3/22;;F01N3/22;;F01N3/32;;F01N3/32;;F01N3/326;;F01N3/326;;F01N5/04;;F01N13/009;;F01N13/009;;F01N2240/14;;F01N2240/14;;F01N2240/30;;F01N2240/30;;F01N2610/03;;F01N2610/03;;F02B37/166;;F02B37/166;;F02B37/168;;F02B37/168;;F02B39/00;;F02M27/02;;F02M27/02;;Y02T10/12;;Y02T10/12,F01N3/08;;F01N3/20;;F01N3/22;;F01N3/32;;F02B37/16;;F02M23/12,,0,0,,,,ACTIVE
9,EP,A4,EP 1888907 A4,015-934-173-272-009,2011-06-15,2011,EP 06735952 A,2006-02-24,US 2006/0006491 W;;US 11882105 A,2005-04-29,METHOD AND APPARATUS FOR SUPPLYING AIR TO EMISSION ABATEMENT DEVICE BY USE OF TURBOCHARGER,,EMCON TECHNOLOGIES LLC,TAYLOR WILLIAM;;KONG YOUGEN;;HUFFMEYER CHRISTOPHER;;KOZAKIEWICZ TOMASZ;;ABEL JOHN,"FAURECIA EMISSIONS CONTROL TECHNOLOGIES, USA, LLC (2016-02-24)",https://lens.org/015-934-173-272-009,Search Report,no,5,0,12,12,0,F01N3/025;;F01N3/035;;F01N3/0814;;F01N3/0842;;F01N3/106;;F01N3/2033;;F01N3/2066;;F01N3/22;;F01N3/32;;F01N3/326;;F01N2240/14;;F01N2240/30;;F01N2610/03;;F02B37/166;;F02M23/12;;F02M27/02;;F01N13/009;;F02B37/168;;Y02T10/12;;F02B37/00;;F01N5/04;;F02B39/00;;F02M23/12;;F01N2610/03;;F01N3/035;;F01N3/22;;F01N3/106;;F01N3/0842;;F02M27/02;;F01N3/2066;;F01N2240/30;;F01N2240/14;;F01N3/32;;F01N3/0814;;F02B37/166;;F01N3/326;;F01N3/2033;;F01N3/025;;F01N13/009;;F02B37/168;;Y02T10/12,F01N3/00;;F01N5/04,,1,0,,,See also references of WO 2006118637A2,ACTIVE
10,KR,A,KR 20080009218 A,003-060-057-389-453,2008-01-25,2008,KR 20077027651 A,2006-02-24,US 11882105 A;;US 2006/0006491 W,2005-04-29,METHOD AND APPARATUS FOR SUPPLYING AIR TO EMISSION ABATEMENT DEVICE BY USE OF TURBOCHARGER,"An apparatus comprises a combustion engine, an emission abatement device, and a turbocharger. The emission abatement device is fluidly coupled to the engine to receive exhaust gas therefrom. The turbocharger comprises an air compressor that is fluidly coupled to the engine to supply pressurized air to the engine and that is fluidly coupled to the emission abatement device via a flow path not including any combustion section of the engine to supply pressurized air to the emission abatement device. An associated method is disclosed.",EMCON TECHNOLOGIES LLC,TAYLOR WILLIAM;;KONG YOUGEN;;HUFFMEYER CHRISTOPHER;;KOZAKIEWICZ TOMASZ;;ABEL JOHN,,https://lens.org/003-060-057-389-453,Patent Application,no,0,0,12,12,0,F02B37/00;;F02M23/12;;F02M23/12;;F01N3/025;;F01N3/025;;F01N3/035;;F01N3/035;;F01N3/0814;;F01N3/0814;;F01N3/0842;;F01N3/0842;;F01N3/106;;F01N3/106;;F01N3/2033;;F01N3/2033;;F01N3/2066;;F01N3/2066;;F01N3/22;;F01N3/22;;F01N3/32;;F01N3/32;;F01N3/326;;F01N3/326;;F01N5/04;;F01N13/009;;F01N13/009;;F01N2240/14;;F01N2240/14;;F01N2240/30;;F01N2240/30;;F01N2610/03;;F01N2610/03;;F02B37/166;;F02B37/166;;F02B37/168;;F02B37/168;;F02B39/00;;F02M27/02;;F02M27/02;;Y02T10/12;;Y02T10/12,F02B37/00;;F01N5/04;;F02B39/00;;F02M25/07,,0,0,,,,ACTIVE
11,EP,A2,EP 1888907 A2,099-490-105-419-534,2008-02-20,2008,EP 06735952 A,2006-02-24,US 2006/0006491 W;;US 11882105 A,2005-04-29,METHOD AND APPARATUS FOR SUPPLYING AIR TO EMISSION ABATEMENT DEVICE BY USE OF TURBOCHARGER,,EMCON TECHNOLOGIES LLC,TAYLOR WILLIAM;;KONG YOUGEN;;HUFFMEYER CHRISTOPHER;;KOZAKIEWICZ TOMASZ;;ABEL JOHN,"FAURECIA EMISSIONS CONTROL TECHNOLOGIES, USA, LLC (2016-02-24)",https://lens.org/099-490-105-419-534,Patent Application,yes,0,0,12,12,0,F02B37/00;;F02M23/12;;F02M23/12;;F01N3/025;;F01N3/025;;F01N3/035;;F01N3/035;;F01N3/0814;;F01N3/0814;;F01N3/0842;;F01N3/0842;;F01N3/106;;F01N3/106;;F01N3/2033;;F01N3/2033;;F01N3/2066;;F01N3/2066;;F01N3/22;;F01N3/22;;F01N3/32;;F01N3/32;;F01N3/326;;F01N3/326;;F01N5/04;;F01N13/009;;F01N13/009;;F01N2240/14;;F01N2240/14;;F01N2240/30;;F01N2240/30;;F01N2610/03;;F01N2610/03;;F02B37/166;;F02B37/166;;F02B37/168;;F02B37/168;;F02B39/00;;F02M27/02;;F02M27/02;;Y02T10/12;;Y02T10/12,F01N3/08;;F01N3/20;;F01N3/22;;F01N3/32;;F02B37/16;;F02M23/12,,0,0,,,,ACTIVE
12,CN,A,CN 101208501 A,047-368-465-185-588,2008-06-25,2008,CN 200680014530 A,2006-02-24,US 11882105 A,2005-04-29,Method and apparatus for supplying air to emission abatement device by use of turbocharger,,ARVIN TECHNOLOGIES INC,WILLIAM TAYLOR;;YOUGEN KONG;;CHRISTOPHER HUFFMEYER;;TOMASZ KOZAKIEWICZ;;JOHN ABEL,,https://lens.org/047-368-465-185-588,Patent Application,no,0,3,12,12,0,F02B37/00;;F02M23/12;;F02M23/12;;F01N3/025;;F01N3/025;;F01N3/035;;F01N3/035;;F01N3/0814;;F01N3/0814;;F01N3/0842;;F01N3/0842;;F01N3/106;;F01N3/106;;F01N3/2033;;F01N3/2033;;F01N3/2066;;F01N3/2066;;F01N3/22;;F01N3/22;;F01N3/32;;F01N3/32;;F01N3/326;;F01N3/326;;F01N5/04;;F01N13/009;;F01N13/009;;F01N2240/14;;F01N2240/14;;F01N2240/30;;F01N2240/30;;F01N2610/03;;F01N2610/03;;F02B37/166;;F02B37/166;;F02B37/168;;F02B37/168;;F02B39/00;;F02M27/02;;F02M27/02;;Y02T10/12;;Y02T10/12,F01N5/04;;F01N3/00,,0,0,,,,DISCONTINUED
13,US,A1,US 2006/0242946 A1,174-493-329-459-465,2006-11-02,2006,US 11882105 A,2005-04-29,US 11882105 A,2005-04-29,Method and apparatus for supplying air to emission abatement device by use of turbocharger,"An apparatus comprises a combustion engine, an emission abatement device, and a turbocharger. The emission abatement device is fluidly coupled to the engine to receive exhaust gas therefrom. The turbocharger comprises an air compressor that is fluidly coupled to the engine to supply pressurized air to the engine and that is fluidly coupled to the emission abatement device via a flow path not including any combustion section of the engine to supply pressurized air to the emission abatement device. An associated method is disclosed.",ARVIN TECHNOLOGIES INC,TAYLOR WILLIAM III;;KONG YOUGEN;;HUFFMEYER CHRISTOPHER R;;KOZAKIEWICZ TOMASZ;;ABEL JOHN,ARVIN TECHNOLOGIES INC (2005-04-29);;ET US HOLDINGS LLC (2007-05-16),https://lens.org/174-493-329-459-465,Patent Application,yes,91,16,12,12,0,F02B37/00;;F02M23/12;;F02M23/12;;F01N3/025;;F01N3/025;;F01N3/035;;F01N3/035;;F01N3/0814;;F01N3/0814;;F01N3/0842;;F01N3/0842;;F01N3/106;;F01N3/106;;F01N3/2033;;F01N3/2033;;F01N3/2066;;F01N3/2066;;F01N3/22;;F01N3/22;;F01N3/32;;F01N3/32;;F01N3/326;;F01N3/326;;F01N5/04;;F01N13/009;;F01N13/009;;F01N2240/14;;F01N2240/14;;F01N2240/30;;F01N2240/30;;F01N2610/03;;F01N2610/03;;F02B37/166;;F02B37/166;;F02B37/168;;F02B37/168;;F02B39/00;;F02M27/02;;F02M27/02;;Y02T10/12;;Y02T10/12,F02M25/06;;F01N5/04;;F02B29/04,60/279;;60/280;;60/599,0,0,,,,INACTIVE
14,US,B2,US 7464539 B2,151-854-762-538-89X,2008-12-16,2008,US 11882105 A,2005-04-29,US 11882105 A,2005-04-29,Method and apparatus for supplying air to emission abatement device by use of turbocharger,"An apparatus comprises a combustion engine, an emission abatement device, and a turbocharger. The emission abatement device is fluidly coupled to the engine to receive exhaust gas therefrom. The turbocharger comprises an air compressor that is fluidly coupled to the engine to supply pressurized air to the engine and that is fluidly coupled to the emission abatement device via a flow path not including any combustion section of the engine to supply pressurized air to the emission abatement device. An associated method is disclosed.",EMCON TECHNOLOGIES LLC,TAYLOR III WILLIAM;;KONG YOUGEN;;HUFFMEYER CHRISTOPHER R;;KOZAKIEWICZ TOMASZ;;ABEL JOHN,ARVIN TECHNOLOGIES INC (2005-04-29);;ET US HOLDINGS LLC (2007-05-16),https://lens.org/151-854-762-538-89X,Granted Patent,yes,17,5,12,12,0,F02B37/00;;F02M23/12;;F02M23/12;;F01N3/025;;F01N3/025;;F01N3/035;;F01N3/035;;F01N3/0814;;F01N3/0814;;F01N3/0842;;F01N3/0842;;F01N3/106;;F01N3/106;;F01N3/2033;;F01N3/2033;;F01N3/2066;;F01N3/2066;;F01N3/22;;F01N3/22;;F01N3/32;;F01N3/32;;F01N3/326;;F01N3/326;;F01N5/04;;F01N13/009;;F01N13/009;;F01N2240/14;;F01N2240/14;;F01N2240/30;;F01N2240/30;;F01N2610/03;;F01N2610/03;;F02B37/166;;F02B37/166;;F02B37/168;;F02B37/168;;F02B39/00;;F02M27/02;;F02M27/02;;Y02T10/12;;Y02T10/12,F01N5/04,60/280;;60/274;;60/278;;60/289;;60/293;;60/295,0,0,,,,INACTIVE
15,EP,A1,EP 4109459 A1,039-392-517-407-710,2022-12-28,2022,EP 22180554 A,2022-06-22,US 202163213625 P;;US 202217693151 A;;US 202217735750 A;;US 202217844618 A,2021-06-22,ATMOSPHERIC MIRRORING AND DYNAMICALLY VARYING THREE-DIMENSIONAL ASSISTANT ADDISON INTERFACE FOR BEHAVIORAL ENVIRONMENTS,"Exemplary embodiments include an intelligent secure networked health messaging system configured by at least one processor to execute instructions stored in memory, the system including a data retention system and a health analytics system, the health analytics system performing asynchronous processing with a patient's computing device and the health analytics system communicatively coupled to a deep neural network, a web services layer providing access to the data retention and the health analytics system, a batching service, wherein an application server layer transmits a request to the web services layer for data, the request processed by the batching service transparently to the patient, the request processed by the batching service transparently to the patient such that the patient can continue to use a patient facing application without disruption, and the patient-facing application having an audio sensor and a computer video sensor.
",ELECTRONIC CAREGIVER INC,DOHRMANN ANTHONY;;SALCIDO ROBERTO ABEL;;KEELEY DAVID W;;BLAKE SAMUEL;;MARKLE MADISON ANNE;;GUERRERO SIERRA DANIELLE;;BUNKER TAYLOR ALLEN;;TVEITO JUDAH,,https://lens.org/039-392-517-407-710,Patent Application,yes,7,0,1,26,0,G16H50/20;;G16H20/10;;G16H20/30;;G16H20/70;;G16H50/70;;G06N3/006;;G06N3/084,G16H20/10;;G06N3/02;;G16H20/30;;G16H20/70;;G16H50/20;;G16H50/70,,0,0,,,,DISCONTINUED
16,EP,A1,EP 4109460 A1,191-751-339-888-98X,2022-12-28,2022,EP 22180558 A,2022-06-22,US 202163213625 P;;US 202217693151 A;;US 202217735750 A;;US 202217844614 A,2021-06-22,ATMOSPHERIC MIRRORING AND DYNAMICALLY VARYING THREE-DIMENSIONAL ASSISTANT ADDISON INTERFACE FOR INTERIOR ENVIRONMENTS,"Exemplary embodiments include an intelligent secure networked health messaging system configured by at least one processor to execute instructions stored in memory, the system including a data retention system and a health analytics system, the health analytics system performing asynchronous processing with a patient's computing device and the health analytics system communicatively coupled to a deep neural network, a web services layer providing access to the data retention and the health analytics system, a batching service, wherein an application server layer transmits a request to the web services layer for data, the request processed by the batching service transparently to the patient, the request processed by the batching service transparently to the patient such that the patient can continue to use a patient facing application without disruption, and the patient-facing application having an audio sensor and a computer video sensor.
",ELECTRONIC CAREGIVER INC,DOHRMANN ANTHONY;;SALCIDO ROBERTO ABEL;;KEELEY DAVID W;;BLAKE SAMUEL;;MARKLE MADISON ANNE;;GUERRERO SIERRA DANIELLE;;BUNKER TAYLOR ALLEN;;TVEITO JUDAH,,https://lens.org/191-751-339-888-98X,Patent Application,yes,9,0,1,26,0,G16H20/10;;G16H20/30;;G16H20/70;;G16H50/20;;G16H50/70;;G06N3/0499;;G06N3/084,G16H20/10;;G06N3/02;;G16H20/30;;G16H20/70;;G16H50/20;;G16H50/70,,0,0,,,,DISCONTINUED
17,EP,A1,EP 4109461 A1,095-304-190-794-592,2022-12-28,2022,EP 22180561 A,2022-06-22,US 202163213625 P;;US 202217693151 A;;US 202217735750 A;;US 202217844619 A,2021-06-22,ATMOSPHERIC MIRRORING AND DYNAMICALLY VARYING THREE-DIMENSIONAL ASSISTANT ADDISON INTERFACE FOR EXTERNAL ENVIRONMENTS,"Exemplary embodiments include an intelligent secure networked health messaging system configured by at least one processor to execute instructions stored in memory, the system including a data retention system and a health analytics system, the health analytics system performing asynchronous processing with a patient's computing device and the health analytics system communicatively coupled to a deep neural network, a web services layer providing access to the data retention and the health analytics system, a batching service, wherein an application server layer transmits a request to the web services layer for data, the request processed by the batching service transparently to the patient, the request processed by the batching service transparently to the patient such that the patient can continue to use a patient facing application without disruption, and the patient-facing application having an audio sensor and a computer video sensor.
",ELECTRONIC CAREGIVER INC,DOHRMANN ANTHONY;;SALCIDO ROBERTO ABEL;;KEELEY DAVID W;;BLAKE SAMUEL;;MARKLE MADISON ANNE;;GUERRERO SIERRA DANIELLE;;BUNKER TAYLOR ALLEN;;TVEITO JUDAH,,https://lens.org/095-304-190-794-592,Patent Application,yes,9,0,1,26,0,G16H20/10;;G16H20/30;;G16H20/70;;G16H50/20;;G16H50/70;;G06N3/084,G16H20/10;;G06N3/02;;G16H20/30;;G16H20/70;;G16H50/20;;G16H50/70,,0,0,,,,DISCONTINUED
18,US,A1,US 2022/0319714 A1,093-259-647-238-914,2022-10-06,2022,US 202217844618 A,2022-06-20,US 202217844618 A;;US 202217735750 A;;US 202217693151 A;;US 201816169760 A;;US 202017013357 A;;US 201615530185 A;;US 202163213625 P;;US 202163184060 P;;US 201862618550 P;;US 201562386768 P,2015-12-11,ATMOSPHERIC MIRRORING AND DYNAMICALLY VARYING THREE-DIMENSIONAL ASSISTANT ADDISON INTERFACE FOR BEHAVIORAL ENVIRONMENTS,"Exemplary embodiments include an intelligent secure networked health messaging system configured by at least one processor to execute instructions stored in memory, the system including a data retention system and a health analytics system, the health analytics system performing asynchronous processing with a patient's computing device and the health analytics system communicatively coupled to a deep neural network, a web services layer providing access to the data retention and the health analytics system, a batching service, wherein an application server layer transmits a request to the web services layer for data, the request processed by the batching service transparently to the patient, the request processed by the batching service transparently to the patient such that the patient can continue to use a patient facing application without disruption, and the patient-facing application having an audio sensor and a computer video sensor.",ELECTRONIC CAREGIVER INC,DOHRMANN ANTHONY;;SALCIDO ROBERTO ABEL;;KEELEY DAVID W;;BLAKE SAMUEL;;MARKLE MADISON ANNE;;GUERRERO SIERRA DANIELLE;;BUNKER TAYLOR ALLEN;;TVEITO JUDAH,ELECTRONIC CAREGIVER INC (2022-07-27),https://lens.org/093-259-647-238-914,Patent Application,yes,0,2,1,26,0,G16H20/10;;G16H40/63;;G16H40/67;;G16H50/20;;G16H50/70;;G16H10/60;;G16H80/00;;G16H15/00;;G16H50/30;;G16H50/30;;G10L2015/223;;G10L15/22;;G16H50/20,G16H50/30;;G10L15/22;;G16H50/20,,0,0,,,,PENDING
19,US,A1,US 2022/0319696 A1,018-294-042-704-461,2022-10-06,2022,US 202217844619 A,2022-06-20,US 202217844619 A;;US 202217735750 A;;US 202217693151 A;;US 201816169760 A;;US 202017013357 A;;US 201615530185 A;;US 202163213625 P;;US 202163184060 P;;US 201862618550 P;;US 201562386768 P,2015-12-11,ATMOSPHERIC MIRRORING AND DYNAMICALLY VARYING THREE-DIMENSIONAL ASSISTANT ADDISON INTERFACE FOR EXTERNAL ENVIRONMENTS,"Exemplary embodiments include an intelligent secure networked health messaging system configured by at least one processor to execute instructions stored in memory, the system including a data retention system and a health analytics system, the health analytics system performing asynchronous processing with a patient's computing device and the health analytics system communicatively coupled to a deep neural network, a web services layer providing access to the data retention and the health analytics system, a batching service, wherein an application server layer transmits a request to the web services layer for data, the request processed by the batching service transparently to the patient, the request processed by the batching service transparently to the patient such that the patient can continue to use a patient facing application without disruption, and the patient-facing application having an audio sensor and a computer video sensor.",ELECTRONIC CAREGIVER INC,DOHRMANN ANTHONY;;SALCIDO ROBERTO ABEL;;KEELEY DAVID W;;BLAKE SAMUEL;;MARKLE MADISON ANNE;;GUERRERO SIERRA DANIELLE;;BUNKER TAYLOR ALLEN;;TVEITO JUDAH,ELECTRONIC CAREGIVER INC (2022-07-27),https://lens.org/018-294-042-704-461,Patent Application,yes,0,0,1,26,0,G16H10/60;;G16H40/67;;G16H50/30;;G16H80/00;;G16H40/67;;G16H80/00;;G16H10/60,G16H40/67;;G16H10/60;;G16H80/00,,0,0,,,,PENDING
20,US,A1,US 2022/0319713 A1,157-197-821-797-092,2022-10-06,2022,US 202217844614 A,2022-06-20,US 202217844614 A;;US 202217735750 A;;US 202217693151 A;;US 201816169760 A;;US 202017013357 A;;US 201615530185 A;;US 202163213625 P;;US 202163184060 P;;US 201862618550 P;;US 201562386768 P,2015-12-11,ATMOSPHERIC MIRRORING AND DYNAMICALLY VARYING THREE-DIMENSIONAL ASSISTANT ADDISON INTERFACE FOR INTERIOR ENVIRONMENTS,"Exemplary embodiments include an intelligent secure networked health messaging system configured by at least one processor to execute instructions stored in memory, the system including a data retention system and a health analytics system, the health analytics system performing asynchronous processing with a patient's computing device and the health analytics system communicatively coupled to a deep neural network, a web services layer providing access to the data retention and the health analytics system, a batching service, wherein an application server layer transmits a request to the web services layer for data, the request processed by the batching service transparently to the patient, the request processed by the batching service transparently to the patient such that the patient can continue to use a patient facing application without disruption, and the patient-facing application having an audio sensor and a computer video sensor.",ELECTRONIC CAREGIVER INC,DOHRMANN ANTHONY;;SALCIDO ROBERTO ABEL;;KEELEY DAVID W;;BLAKE SAMUEL;;MARKLE MADISON ANNE;;GUERRERO SIERRA DANIELLE;;BUNKER TAYLOR ALLEN;;TVEITO JUDAH,ELECTRONIC CAREGIVER INC (2022-07-27),https://lens.org/157-197-821-797-092,Patent Application,yes,0,2,1,26,0,G16H40/67;;G16H40/63;;G16H10/60;;G16H50/20;;G16H20/10;;G16H80/00;;G16H50/30;;G10L25/30;;G10L25/66;;G10L15/26;;G16H50/30;;G16H50/20;;G10L2015/223;;G16H40/60;;G10L15/22,G16H50/30;;G10L15/22;;G16H40/60;;G16H50/20,,0,0,,,,PENDING
21,WO,A1,WO 2021/026130 A1,172-568-323-658-579,2021-02-11,2021,US 2020/0044851 W,2020-08-04,US 201962940005 P;;US 202063023559 P;;US 202063030581 P;;US 201962883085 P;;US 201962883943 P;;US 201962930370 P,2019-08-05,COMPOSITIONS AND METHODS OF TREATING PSORIASIS AND ATOPIC DERMATITIS USING PREVOTELLA HISTICOLA,"Provided herein are methods and compositions related to Prevotella bacteria useful as therapeutic agents, e.g. , for the treatment of psoriasis or atopic dermatitis.",EVELO BIOSCIENCES INC,ABEL S;;BARTH KRISTIE;;BODMER MARK;;CORMACK TAYLOR;;GANGULY TANMOY;;GARDNER HUMPHREY;;ITANO ANDREA;;MCHALE DUNCAN;;NOOR MUSTAFA;;PONICHTERA HOLLY;;RAMANI KRITIKA;;SANDY PETER,,https://lens.org/172-568-323-658-579,Patent Application,yes,4,6,12,13,69,A61K35/74;;A61K9/2806;;A61K9/4891;;A61P17/06;;A61P17/00;;A61P37/08;;A61P29/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61P17/06;;A61P17/00;;A61K9/0053;;A61K35/74;;A61K2035/11,A61P17/06;;A61K35/74;;A61K35/741;;A61P37/00,,51,47,077-711-317-034-730;;009-846-967-315-456;;028-684-183-887-851;;026-714-374-369-223;;069-542-545-735-809;;126-746-088-759-759;;085-764-009-624-439;;066-141-497-990-023;;056-201-471-905-934;;005-663-818-775-064;;030-892-005-608-90X;;069-190-301-346-413;;024-021-129-662-528;;001-033-748-832-198;;083-733-615-337-451;;020-663-516-602-225;;038-653-423-075-782;;020-774-195-097-652;;056-008-196-471-910;;060-053-579-951-417;;018-924-582-462-76X;;077-711-317-034-730;;030-308-555-015-10X;;002-716-123-063-631;;005-776-196-239-400;;010-660-058-395-604;;128-362-999-717-250;;034-104-672-621-644;;029-629-527-137-240;;084-768-376-821-866;;007-855-186-100-761;;033-164-849-120-30X;;007-803-303-366-055;;073-171-657-787-990;;116-476-143-529-930;;050-026-253-640-954;;052-700-760-835-371;;077-711-317-034-730;;002-331-952-927-161;;025-496-295-869-95X;;021-930-578-656-827;;063-720-189-443-412;;010-717-895-477-185;;014-911-872-192-907;;051-096-137-293-692;;087-011-397-145-515;;009-000-465-769-176,pmc5125894;;27337150;;10.1002/art.39785;;30984162;;pmc6448018;;10.3389/fimmu.2019.00462;;10.1080/14737175.2019.1555473;;30513004;;pmc6548683;;10.5270/esa-qzxdorb;;pmc1764935;;17062412;;10.1098/rstb.2006.1920;;18461076;;10.1038/nrmicro1872;;10.1073/pnas.85.8.2444;;pmc280013;;3162770;;10.1093/nar/12.1part1.387;;6546423;;pmc321012;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;8033378;;10.1111/j.1365-2230.1994.tb01167.x;;pmc5494988;;10.1016/j.chom.2017.04.002;;28494240;;10.1111/j.1742-7843.2006.pto_298.x;;16918710;;17429444;;10.1038/sj.jid.5700807;;19380832;;10.4049/jimmunol.0802999;;28706993;;pmc5507635;;10.1126/sciadv.1700492;;pmc2930426;;20679230;;10.1073/pnas.1005963107;;29451320;;pmc6005602;;10.1111/bcp.13550;;28883543;;pmc5880576;;10.1038/ijo.2017.220;;pmc4931233;;27352007;;10.1038/ncomms12015;;10.1002/9781119968535.ch17;;28793252;;10.1016/j.celrep.2017.07.031;;pmc5763484;;pmc5125894;;27337150;;10.1002/art.39785;;pmc4569432;;10.1371/journal.pone.0137429;;26367776;;28797298;;pmc5553673;;10.1186/s40168-017-0320-4;;23149072;;10.1016/j.numecd.2012.09.002;;21885731;;pmc3368382;;10.1126/science.1208344;;10.1111/apt.13746;;27492648;;10.1002/bimj.201300138;;24984691;;10.3109/09546634.2012.742950;;23092173;;17216680;;10.1371/journal.pone.0188475;;29211757;;pmc5718513;;pmc1766877;;10.1136/ard.2004.031237;;15708941;;28984367;;pmc5889363;;10.1111/nyas.13508;;22588748;;10.1002/acr.20543;;28960186;;10.1038/nrneurol.2017.142;;10.1038/nature11209;;pmc3377744;;22699610;;10.1016/j.jaad.2004.04.012;;15389191;;pmc5125894;;27337150;;10.1002/art.39785;;pmc1662249;;2107897;;10.1136/bmj.300.6722.439;;10.1177/247553031117a00403;;10.1111/bjd.15375;;28182255;;15468350;;10.1023/a:1022269315437;;12639065;;pmc4717365;;10.1136/gutjnl-2015-309618;;26069274;;29143816;;10.1038/nature24460;;10.1016/j.jaad.2013.07.040;;24054760;;28804689;;10.1007/s13671-017-0178-5;;pmc5552074,"ERIC V. MARIETTA ET AL: ""Suppression of Inflammatory Arthritis by Human Gut-Derived Prevotella histicola in Humanized Mice : SUPPRESSION OF INFLAMMATORY ARTHRITIS BY PREVOTELLA HISTICOLA"", ARTHRITIS & RHEUMATOLOGY (HOBOKEN), vol. 68, no. 12, 28 November 2016 (2016-11-28), US, pages 2878 - 2888, XP055665204, ISSN: 2326-5191, DOI: 10.1002/art.39785;;SHAILESH K. SHAHI ET AL: ""Prevotella histicola, A Human Gut Commensal, Is as Potent as COPAXONE in an Animal Model of Multiple Sclerosis"", FRONTIERS IN IMMUNOLOGY, vol. 10, 1 January 2019 (2019-01-01), pages 462, XP055741469, DOI: 10.3389/fimmu.2019.00462;;ASHUTOSH K. MANGALAM ET AL: ""Microbial monotherapy with Prevotella histicola for patients with multiple sclerosis"", EXPERT REVIEW OF NEUROTHERAPEUTICS, vol. 19, no. 1, 10 December 2018 (2018-12-10), GB, pages 45 - 53, XP055741668, ISSN: 1473-7175, DOI: 10.1080/14737175.2019.1555473;;""NRRL"", Database accession no. B 50329;;KONSTANTINIDIS K TRAMETTE ATIEDJE J M, NUCLEIC ACIDS RES, vol. 38, 2006, pages e200;;KONSTANTINIDIS K TRAMETTE ATIEDJE J M: ""The bacterial species definition in the genomic era"", PHILOS TRANS R SOC LOND B BIOL SCI, vol. 361, 2006, pages 1929 - 1940;;ACHTMAN MWAGNER M: ""Microbial diversity and the genetic nature of microbial species"", NAT. REV. MICROBIOL., vol. 6, 2008, pages 431 - 440, XP055597710, DOI: 10.1038/nrmicro1872;;PEARSON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 2444;;DEVEREUX, J. ET AL., NUCLEIC ACIDS RESEARCH, vol. 12, no. I, 1984, pages 387;;ATSCHUL, S. F. ET AL., J MOLEC BIOL, vol. 215, 1990, pages 403;;FINLAY AYKHAN GK: ""Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use"", CLIN EXP DERMATOL, vol. 19, 1994, pages 210 - 6;;CARILLO ET AL., SIAM J APPLIED MATH, vol. 48, 1988, pages 1073;;CABALLERO ET AL.: ""Cooperating Commensals Restore Colonization Resistance to Vancomycin-Resistant Enterococcus faecium"", CELL HOST & MICROBE, vol. 21, 2017, pages 592 - 602;;PETERSEN ET AL.: ""In vivo pharmacological disease models for psoriasis and atopic dermatitis in drug discovery"", BASIC & CLINICAL PHARM & TOXICOLOGY, vol. 99, no. 2, 2006, pages 104 - 115, XP055360626, DOI: 10.1111/j.1742-7843.2006.pto_298.x;;""Mouse Models of Innate Immunity: Methods and Protocols"", METHODS IN MOLECULAR BIOLOGY, vol. 1031, 2013;;GUDJONSSON ET AL.: ""Mouse models of psoriasis"", J INVEST DERM, vol. 127, 2007, pages 1292 - 1308, XP002692852, DOI: 10.1038/sj.jid.5700807;;VAN DER FITS ET AL.: ""Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis"", J. IMMUNOL., vol. 182, no. 9, 1 May 2009 (2009-05-01), pages 5836 - 45, XP055376245, DOI: 10.4049/jimmunol.0802999;;COSORICH IDALLA-COSTA GSORINI CFERRARESE RMESSINA MJDOLPADY J ET AL.: ""High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis"", SCI ADV, vol. 3, no. 7, 2017, pages e1700492;;DE FILIPPO CCAVALIERI DDI PAOLA MRAMAZZOTTI MPOULLET JBMASSART S ET AL.: ""Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa"", PROC NATL ACAD SCI USA, vol. 107, no. 33, 2010, pages 14691 - 14696;;EMA CHMP GUIDELINE ON STRATEGIES TO IDENTIFY AND MITIGATE RISKS FOR FIRST-IN-HUMAN AND EARLY CLINICAL TRIALS WITH INVESTIGATIONAL MEDICINAL PRODUCTS, 20 July 2017 (2017-07-20);;US DEPARTMENT OF HEALTH AND HUMAN SERVICESFDA CENTER FOR DRUG EVALUATION AND RESEARCH (CDERCENTER FOR BIOLOGIES EVALUATION AND RES: ""Drug-induced liver injury: premarketing clinical evaluation"", FDA GUIDANCE FOR INDUSTRY, July 2009 (2009-07-01);;HJORTH MFROAGER HMLARSEN TMPOULSEN SKLICHT TRBAHL MI ET AL.: ""Pre-treatment microbial Prevotella-to-Bacteroides ratio, determines body fat loss success during a 6-month randomized controlled diet intervention"", INT J OBES (LOND, vol. 42, no. 3, 2018, pages 580 - 583, XP055674991, DOI: 10.1038/ijo.2017.220;;JANGI SGANDHI RCOX LMLI NVON GLEHN FYAN R ET AL.: ""Alterations of the human gut microbiome in multiple sclerosis"", NAT COMMUN, vol. 7, 2016, pages 12015;;KARASOV WH: ""Metabolic Ecology: A Scaling Approach. Hoboken, NJ"", 2012, WILEY-BLACKWELL, article ""Terrestrial vertebrates"", pages: 212 - 224;;MANGALAM ASHAHI SKLUCKEY DKARAU MMARIETTA ELUO N ET AL.: ""Human gut-derived commensal bacteria suppress CNS inflammatory and demyelinating disease"", CELL REP, vol. 20, no. 6, 2017, pages 1269 - 1277;;MARIETTA EVMURRAY JALUCKEY DHJERALDO PRLAMBA APATEL R ET AL.: ""Suppression of inflammatory arthritis by human gut-derived prevotella histicola in humanized mice"", ARTHRITIS RHEUMATOL, vol. 68, no. 12, 2016, pages 2878 - 2888, XP055665204, DOI: 10.1002/art.39785;;MIYAKE SKIM SSUDA WOSHIMA KNAKAMURA MMATSUOKA T ET AL.: ""Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters"", PLOS ONE, vol. 10, no. 9, 2015, pages e0137429, XP055372632, DOI: 10.1371/journal.pone.0137429;;PETERSEN LMBAUTISTA EJNGUYEN HHANSON BMCHEN LLEK SH ET AL.: ""Community characteristics of the gut microbiomes of competitive cyclists"", MICROBIOME, vol. 5, no. 1, 2017, pages 98, XP021247767, DOI: 10.1186/s40168-017-0320-4;;TAGLIABUE AELLI M: ""The role of gut microbiota in human obesity: Recent findings and future perspectives"", NUTR METAB CARDIOVASC DIS, vol. 23, no. 3, 2013, pages 160 - 168, XP028998424, DOI: 10.1016/j.numecd.2012.09.002;;WU GDCHEN JHOFFMANN CBITTINGER KCHEN YYKEILBAUGH SA ET AL.: ""Linking long-term dietary patterns with gut microbial enterotypes"", SCIENCE, vol. 334, no. 6052, 2011, pages 105 - 108, XP055552796, DOI: 10.1126/science.1210301;;BLAKE MRRAKER JMWHELAN K: ""Validity and reliability of the Bristol Stool Form Scale in healthy adults and patients with diarrhoea-predominant irritable bowel syndrome"", ALIMENT PHARMACOL THER, vol. 44, 2016, pages 693 - 703;;BORNKAMP B: ""Practical considerations for using functional uniform prior distributions for dose-response estimation in clinical trials"", BIOM J, vol. 56, no. 6, 2014, pages 947 - 62;;BUSHNELL DMMARTIN MLMCCARRIER K ET AL.: ""Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity"", J DERMATOLOG TREAT, vol. 24, no. 5, 2013, pages 356 - 60;;CASSELL SEBIEBER JDRICH P ET AL.: ""The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis"", J RHEUMATOL, vol. 34, no. l, January 2007 (2007-01-01), pages 123 - 9;;DE GROOT PFBELZER CAYDIN O ET AL.: ""Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study"", PLOS ONE, vol. 12, no. 12, 2017, pages e0188475;;FELDMAN SRKRUEGER GG: ""Psoriasis assessment tools in clinical trials"", ANN RHEUM DIS, vol. 64, no. 2, 2005, pages ii65 - 8;;FELIX KMTAHSIN SWU HJ: ""Host-microbiota interplay in mediating immune disorders"", ANN N Y ACAD SCI, vol. 1417, no. 1, 2018, pages 57 - 70;;HAWKER GAMIAN SKENDZERSKA T ET AL.: ""Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), ShortOForm McGill Pain Questionnaire (SFDMPQ), Chronic Pain Grade Scale (CPGS), Short Form 0 36 Bodily Pain Scale (SF036 BPS), and Measure of Intermittent and C"", ARTHRITIS CARE RES (HOBOKEN, vol. 63, no. 11, 2011, pages S240 - 52;;HINDSON J: ""Multiple sclerosis: A possible link between multiple sclerosis and gut microbiota"", NAT REV NEUROL, vol. 13, no. 12, 2017, pages 705;;""Human Microbiome Project Consortium. A framework for human microbiome research"", NATURE, vol. 486, 2012, pages 215 - 21;;LANGLEY RGELLIS CN: ""Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment"", J AM ACAD DERMATOL, vol. 51, no. 4, 2004, pages 563 - 9, XP004590820, DOI: 10.1016/j.jaad.2004.04.012;;MARIETTA EVMURRAY JALUCKEY DH ET AL.: ""Human gut-derived Prevotella histicola suppresses inflammatory arthritis in humanized mice"", ARTHRITIS RHEUMATOL, vol. 68, no. 12, 2016, pages 2878 - 88, XP055665204, DOI: 10.1002/art.39785;;O'DONNELL LJDVIRJEE JHEATON KW: ""Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate"", BMJ, vol. 300, 1990, pages 439 - 40;;PATEL RVTSUI CL: ""Evaluating psoriasis: a review of the assessments most commonly used in clinical trials"", PSORIASIS FORUM, vol. 17, no. 4, 2011, pages 259 - 66;;SKOIE IMDALEN ITERNOWITZ T ET AL.: ""Fatigue in psoriasis: a controlled study"", BR J DERMATOL, vol. 177, no. 2, 2017, pages 505 - 12;;WOLFE F: ""Fatigue assessments in rheumatoid arthritis: comparative performance of visual analog scales and longer fatigue questionnaires in 7760 patients"", J RHEUMATOL, vol. 31, no. 10, 2004, pages 1896 - 902;;VAN DER HEIJDEN PGVAN BUUREN SFEKKES M ET AL.: ""Unidimensionality and reliability under Mokken scaling of the Dutch language version of the SF-36"", QUAL LIFE RES, vol. 12, 2003, pages 189 - 98;;VANDEPUTTE DFALONY GVIEIRA-SILVA S ET AL.: ""Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates"", GUT, vol. 65, 2016, pages 57 - 62;;VANDEPUTTE DKATHAGEN GD'HOE K ET AL.: ""Quantitative microbiome profiling links gut community variation to microbial load"", NATURE, vol. 551, 2017, pages 507 - 11, XP037202979, DOI: 10.1038/nature24460;;WALSH JAMCFADDEN MWOODCOCK J ET AL.: ""Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort"", J AM ACAD DERMATOL, vol. 69, no. 6, 2013, pages 931 - 7;;YAN DISSA NAFIFI L ET AL.: ""The role of the skin and gut microbiome in psoriatic disease"", CURR DERMATOL REP, vol. 6, 2017, pages 94 - 103",PENDING
22,AU,A1,AU 2020/324970 A1,009-318-072-574-191,2022-02-24,2022,AU 2020/324970 A,2020-08-04,US 202063023559 P;;US 201962940005 P;;US 201962883085 P;;US 201962930370 P;;US 202063030581 P;;US 201962883943 P;;US 2020/0044851 W,2019-08-05,Compositions and methods of treating psoriasis and atopic dermatitis using prevotella histicola,Provided herein are methods and compositions related to,EVELO BIOSCIENCES INC,ABEL S;;BARTH KRISTIE;;BODMER MARK;;CORMACK TAYLOR;;GANGULY TANMOY;;GARDNER HUMPHREY;;ITANO ANDREA;;MCHALE DUNCAN;;NOOR MUSTAFA;;PONICHTERA HOLLY;;RAMANI KRITIKA;;SANDY PETER,,https://lens.org/009-318-072-574-191,Patent Application,no,0,0,12,13,0,A61K35/74;;A61K9/2806;;A61K9/4891;;A61P17/06;;A61P17/00;;A61P37/08;;A61P29/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61P17/06;;A61P17/00;;A61K9/0053;;A61K35/74;;A61K2035/11,A61P17/06;;A61K35/74;;A61K35/741;;A61P37/00,,0,0,,,,PENDING
23,CO,A2,CO 2022002413 A2,184-170-047-871-597,2022-04-08,2022,CO 2022002413 A,2022-02-28,US 2020/0044851 W;;US 201962883085 P;;US 201962883943 P;;US 201962930370 P;;US 201962940005 P;;US 202063023559 P;;US 202063030581 P,2019-08-05,Composiciones y métodos para tratar la psoriasis y la dermatitis atópica usando prevotella histicola,"En el presente documento se proporcionan métodos y composiciones relacionados con las bacterias Prevotella útiles como agentes terapéuticos, por ejemplo, para el tratamiento de la psoriasis o dermatitis atópica.",EVELO BIOSCIENCES INC,BODMER MARK;;CORMACK TAYLOR A;;ITANO ANDREA;;PONICHTERA HOLLY;;RAMANI KRITIKA;;ABEL S M;;BARTH KRISTIE;;GANGULY TANMOY;;GARDNER HUMPHREY;;MCHALE DUNCAN;;NOOR MUSTAFA;;SANDY PETER,,https://lens.org/184-170-047-871-597,Patent Application,no,0,0,12,13,0,A61K35/74;;A61K9/2806;;A61K9/4891;;A61P17/06;;A61P17/00;;A61P37/08;;A61P29/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61P17/06;;A61P17/00;;A61K9/0053;;A61K35/74;;A61K2035/11,A61P17/06;;A61K35/74;;A61K35/741;;A61P37/00,,0,0,,,,PENDING
24,EP,A1,EP 4010077 A1,120-177-097-867-270,2022-06-15,2022,EP 20760666 A,2020-08-04,US 201962883085 P;;US 201962883943 P;;US 201962930370 P;;US 201962940005 P;;US 202063023559 P;;US 202063030581 P;;US 2020/0044851 W,2019-08-05,COMPOSITIONS AND METHODS OF TREATING PSORIASIS AND ATOPIC DERMATITIS USING PREVOTELLA HISTICOLA,,EVELO BIOSCIENCES INC,ABEL S M;;BARTH KRISTIE;;BODMER MARK;;CORMACK TAYLOR A;;GANGULY TANMOY;;GARDNER HUMPHREY;;ITANO ANDREA;;MCHALE DUNCAN;;NOOR MUSTAFA;;PONICHTERA HOLLY;;RAMANI KRITIKA;;SANDY PETER,,https://lens.org/120-177-097-867-270,Patent Application,yes,0,0,12,13,0,A61K35/74;;A61K9/2806;;A61K9/4891;;A61P17/06;;A61P17/00;;A61P37/08;;A61P29/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61P17/06;;A61P17/00;;A61K9/0053;;A61K35/74;;A61K2035/11,A61P17/06;;A61K35/74;;A61K35/741;;A61P37/00,,0,0,,,,PENDING
25,TW,A,TW 202120110 A,192-493-549-574-409,2021-06-01,2021,TW 109126592 A,2020-08-05,US 201962883085 P;;US 201962883943 P;;US 201962930370 P;;US 201962940005 P;;US 202063023559 P;;US 202063030581 P,2019-08-05,Compositions and methods of treating psoriasis and atopic dermatitis using Prevotella histicola,"Provided herein are methods and compositions related to Prevotella bacteria useful as therapeutic agents, e.g., for the treatment of psoriasis or atopic dermatitis.",EVELO BIOSCIENCES INC,ABEL S M;;BARTH KRISTIE;;BODMER MARK;;CORMACK TAYLOR A;;GANGULY TANMOY;;GARDNER HUMPHREY;;ITANO ANDREA;;MCHALE DUNCAN;;NOOR MUSTAFA;;PONICHTERA HOLLY;;RAMANI KRITIKA;;SANDY PETER,,https://lens.org/192-493-549-574-409,Patent of Addition,no,0,0,12,13,0,A61K35/74;;A61K9/2806;;A61K9/4891;;A61P17/06;;A61P17/00;;A61P37/08;;A61P29/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61P17/06;;A61P17/00;;A61K9/0053;;A61K35/74;;A61K2035/11,A61K35/741;;A61P17/06;;A61P37/00,,0,0,,,,PENDING
26,CA,A1,CA 3150041 A1,069-126-683-894-266,2021-02-11,2021,CA 3150041 A,2020-08-04,US 201962883085 P;;US 201962883943 P;;US 201962930370 P;;US 201962940005 P;;US 202063023559 P;;US 202063030581 P;;US 2020/0044851 W,2019-08-05,COMPOSITIONS AND METHODS OF TREATING PSORIASIS AND ATOPIC DERMATITIS USING PREVOTELLA HISTICOLA,"Provided herein are methods and compositions related to Prevotella bacteria useful as therapeutic agents, e.g., for the treatment of psoriasis or atopic dermatitis.",EVELO BIOSCIENCES INC,ABEL S M;;BARTH KRISTIE;;BODMER MARK;;CORMACK TAYLOR A;;GANGULY TANMOY;;GARDNER HUMPHREY;;ITANO ANDREA;;MCHALE DUNCAN;;NOOR MUSTAFA;;PONICHTERA HOLLY;;RAMANI KRITIKA;;SANDY PETER,,https://lens.org/069-126-683-894-266,Patent Application,no,0,0,12,13,69,A61K35/74;;A61K9/2806;;A61K9/4891;;A61P17/06;;A61P17/00;;A61P37/08;;A61P29/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61P17/06;;A61P17/00;;A61K9/0053;;A61K35/74;;A61K2035/11,A61K35/74;;A61P17/06,,0,0,,,,PENDING
27,MX,A,MX 2022001607 A,094-858-832-615-735,2022-03-11,2022,MX 2022001607 A,2020-08-04,US 201962883085 P;;US 201962883943 P;;US 201962930370 P;;US 201962940005 P;;US 202063023559 P;;US 202063030581 P;;US 2020/0044851 W,2019-08-05,COMPOSITIONS AND METHODS OF TREATING PSORIASIS AND ATOPIC DERMATITIS USING PREVOTELLA HISTICOLA.,"Provided herein are methods and compositions related to Prevotella bacteria useful as therapeutic agents, e.g., for the treatment of psoriasis or atopic dermatitis.",EVELO BIOSCIENCES INC,SANDY PETER;;GARDNER HUMPHREY;;PONICHTERA HOLLY;;ITANO ANDREA;;CORMACK TAYLOR A;;MCHALE DUNCAN;;BODMER MARK;;RAMANI KRITIKA;;ABEL S M;;GANGULY TANMOY;;NOOR MUSTAFA;;BARTH KRISTIE,,https://lens.org/094-858-832-615-735,Patent Application,no,0,0,12,13,0,A61K35/74;;A61K9/2806;;A61K9/4891;;A61P17/06;;A61P17/00;;A61P37/08;;A61P29/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61P17/06;;A61P17/00;;A61K9/0053;;A61K35/74;;A61K2035/11,A61K35/741;;A61P17/06;;A61P37/00,,0,0,,,,PENDING
28,KR,A,KR 20220044315 A,169-810-037-422-375,2022-04-07,2022,KR 20227007202 A,2020-08-04,US 201962883085 P;;US 201962883943 P;;US 201962930370 P;;US 201962940005 P;;US 202063023559 P;;US 202063030581 P;;US 2020/0044851 W,2019-08-05,프레보텔라 히스티콜라를 사용한 건선 및 아토피성 피부염을 치료하기 위한 조성물 및 방법,"본 명세서에는 예를 들어, 건선 또는 아토피성 피부염의 치료를 위한, 치료제로서 유용한 프레보텔라 박테리아와 관련된 방법 및 조성물이 제공된다.",EVELO BIOSCIENCES INC,ABEL S M;;BARTH KRISTIE;;BODMER MARK;;CORMACK TAYLOR A;;GANGULY TANMOY;;GARDNER HUMPHREY;;ITANO ANDREA;;MCHALE DUNCAN;;NOOR MUSTAFA;;PONICHTERA HOLLY;;RAMANI KRITIKA;;SANDY PETER,,https://lens.org/169-810-037-422-375,Patent Application,no,0,1,12,13,138,A61K35/74;;A61K9/2806;;A61K9/4891;;A61P17/06;;A61P17/00;;A61P37/08;;A61P29/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61P17/06;;A61P17/00;;A61K9/0053;;A61K35/74;;A61K2035/11,A61K35/741;;A61P17/06;;A61P37/00,,0,0,,,,PENDING
29,BR,A2,BR 112022002150 A2,024-296-399-223-704,2022-06-07,2022,BR 112022002150 A,2020-08-04,US 2020/0044851 W;;US 201962883085 P;;US 201962883943 P;;US 201962930370 P;;US 201962940005 P;;US 202063023559 P;;US 202063030581 P,2019-08-05,Composições e métodos para tratar psoríase e dermatite atópica com o uso de prevotella histicola,"composições e métodos para tratar psoríase e dermatite atópica com o uso de prevotella histicola. a presente invenção refere-se a métodos e composições relacionados a bactérias prevotella úteis como agentes terapêuticos, por exemplo, para o tratamento de psoríase ou dermatite atópica.",EVELO BIOSCIENCES INC,ITANO ANDREA;;MCHALE DUNCAN;;PONICHTERA HOLLY;;GARDNER HUMPHREY;;BARTH KRISTIE;;RAMANI KRITIKA;;BODMER MARK;;NOOR MUSTAFA;;SANDY PETER;;S M ABEL;;GANGULY TANMOY;;TAYLOR A CORMACK,,https://lens.org/024-296-399-223-704,Patent Application,no,0,0,12,13,0,A61K35/74;;A61K9/2806;;A61K9/4891;;A61P17/06;;A61P17/00;;A61P37/08;;A61P29/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61P17/06;;A61P17/00;;A61K9/0053;;A61K35/74;;A61K2035/11,A61K35/74;;A61K35/741;;A61P17/06;;A61P37/00,,0,0,,,,DISCONTINUED
30,AR,A1,AR 122293 A1,003-936-505-943-870,2022-08-31,2022,AR P200102217 A,2020-08-05,US 201962883085 P,2019-08-05,COMPOSICIONES Y MÉTODOS PARA TRATAR LA PSORIASIS Y LA DERMATITIS ATÓPICA UTILIZANDO PREVOTELLA HISTICOLA,"En el presente documento se proporcionan métodos y composiciones relacionados con las bacterias Prevotella útiles como agentes terapéuticos, por ejemplo, para el tratamiento de la psoriasis o dermatitis atópica. Reivindicación 1: Un método para tratar la psoriasis en un sujeto humano que comprende administrar por vía oral al sujeto humano una dosis de 8 ´ 10¹⁰ a 8 ´ 10¹¹ células totales de la cepa B 50329 de Prevotella histicola (n.º de referencia de NRRL B 50329) formulada en una o más cápsulas o comprimidos de recubrimiento entérico.",EVELO BIOSCIENCES INC,ABEL S M;;BARTH KRISTIE;;BODMER MARK;;CORMACK TAYLOR A;;GANGULY TANMOY;;GARDNER HUMPHREY;;ITANO ANDREA;;MCHALE DUNCAN;;NOOR MUSTAFA;;PONICHTERA HOLLY;;RAMANI KRITIKA;;SANDY PETER,,https://lens.org/003-936-505-943-870,Patent Application,no,0,0,1,13,0,,A61K35/74;;A61P17/06;;A61P37/00,,0,0,,,,PENDING
31,US,A1,US 2022/0339208 A1,107-914-405-851-673,2022-10-27,2022,US 202017633105 A,2020-08-04,US 202017633105 A;;US 202063030581 P;;US 202063023559 P;;US 201962940005 P;;US 201962930370 P;;US 201962883943 P;;US 201962883085 P;;US 2020/0044851 W,2019-08-05,COMPOSITIONS AND METHODS OF TREATING PSORIASIS AND ATOPIC DERMATITIS USING PREVOTELLA HISTICOLA,"Provided herein are methods and compositions related to Prevotella bacteria useful as therapeutic agents, e.g., for the treatment of psoriasis or atopic dermatitis.",EVELO BIOSCIENCES INC,ABEL S M;;BARTH KRISTIE;;BODMER MARK;;CORMACK TAYLOR A;;GANGULY TANMOY;;GARDNER HUMPHREY;;ITANO ANDREA;;MCHALE DUNCAN;;NOOR MUSTAFA;;PONICHTERA HOLLY;;RAMANI KRITIKA;;SANDY PETER,EVELO BIOSCIENCES INC (2020-08-10),https://lens.org/107-914-405-851-673,Patent Application,yes,0,5,12,13,69,A61K35/74;;A61K9/2806;;A61K9/4891;;A61P17/06;;A61P17/00;;A61P37/08;;A61P29/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61K35/741;;A61P17/06;;A61P37/00;;A61P17/06;;A61P17/00;;A61K9/0053;;A61K35/74;;A61K2035/11,A61K35/74;;A61K9/00;;A61P17/00;;A61P17/06,,0,0,,,,PENDING
32,WO,A1,WO 1996/006915 A1,050-768-390-764-489,1996-03-07,1996,US 9509181 W,1995-07-20,US 29890394 A,1994-08-31,QUARTERNARY SUBSTITUTED BLEACH ACTIVATORS,"Bleaching compositions, laundry and automatic dishwashing detergent compositions comprising particular quaternary-substituted bleach activators, are provided. More specifically, the invention relates to compositions which provide enhanced cleaning/bleaching benefits though the selection of quaternary-substituted bleach activators having specific leaving groups with a conjugate acid pKa above 13 and with specific ratios of the rate of perhydrolysis to the rate of hydrolysis and the rate of perhydrolysis to the rate of diacylperoxide production. Included are preferred activator compounds and methods for washing fabrics, hard surfaces, and tableware using the activators.",PROCTER & GAMBLE,WILLEY ALAN DAVID;;MIRACLE GREGORY SCOT;;KOTT KEVIN LEE;;BURNS MICHAEL EUGENE;;BAILLELY GERARD MARCEL ABEL;;HARDY FREDERICK EDWARD;;TAYLOR LUCILLE FLORENCE;;SIVIK MARK ROBERT;;GUEDIRA NOUR-EDDINE,,https://lens.org/050-768-390-764-489,Patent Application,yes,4,3,13,13,0,C07D223/10;;C07D233/06;;C11D3/3927;;C07D223/10;;C11D3/3927;;C07D233/06,C07D223/10;;C07D233/06;;C11D3/39;;C11D3/395;;C11D7/54,,4,0,,,"DATABASE WPI Week 9026, Derwent World Patents Index; AN 90-198270;;DATABASE WPI Week 9229, Derwent World Patents Index; AN 92-239922;;DATABASE WPI Week 9023, Derwent World Patents Index; AN 90-175269;;DATABASE WPI Week 9034, Derwent World Patents Index; AN 90-258428",PATENTED
33,CA,A1,CA 2197443 A1,163-199-956-480-064,1996-03-07,1996,CA 2197443 A,1995-07-20,US 29890394 A;;US 9509181 W,1994-08-31,QUARTERNARY SUBSTITUTED BLEACH ACTIVATORS,"Bleaching compositions, laundry and automatic dishwashing detergent compositions comprising particular quaternary-substituted bleach activators, are provided. More specifically, the invention relates to compositions which provide enhanced cleaning/bleaching benefits though the selection of quaternary-substituted bleach activators having specific leaving groups with a conjugate acid pKa above 13 and with specific ratios of the rate of perhydrolysis to the rate of hydrolysis and the rate of perhydrolysis to the rate of diacylperoxide production. Included are preferred activator compounds and methods for washing fabrics, hard surfaces, and tableware using the activators.",PROCTER & GAMBLE,WILLEY ALAN DAVID;;MIRACLE GREGORY SCOT;;KOTT KEVIN LEE;;BURNS MICHAEL EUGENE;;BAILLELY GERARD MARCEL ABEL;;HARDY FREDERICK EDWARD;;TAYLOR LUCILLE FLORENCE;;SIVIK MARK ROBERT;;GUEDIRA NOUR-EDDINE,,https://lens.org/163-199-956-480-064,Patent Application,no,0,0,13,13,0,C07D223/10;;C07D233/06;;C11D3/3927;;C07D223/10;;C11D3/3927;;C07D233/06,C07D223/10;;C07D233/06;;C11D3/39;;C11D3/395;;C11D7/54,,0,0,,,,EXPIRED
34,CA,C,CA 2197443 C,041-753-077-378-620,2001-11-27,2001,CA 2197443 A,1995-07-20,US 29890394 A;;US 9509181 W,1994-08-31,QUARTERNARY SUBSTITUTED BLEACH ACTIVATORS,"Bleaching compositions, laundry and automatic dishwashing detergent compositions comprising particular quaternary-substituted bleach activators, are provided. More specifically, the invention relates to compositions which provide enhanced cleaning/bleaching benefits though the selection of quaternary-substituted bleach activators having specific leaving groups with a conjugate acid pKa above 13 and with specific ratios of the rate of perhydrolysis to the rate of hydrolysis and the rate of perhydrolysis to the rate of diacylperoxide production. Included are preferred activator compound s and methods for washing fabrics, hard surfaces, and tableware using the activators.",PROCTER & GAMBLE,GUEDIRA NOUR-EDDINE;;KOTT KEVIN LEE;;WILLEY ALAN DAVID;;MIRACLE GREGORY SCOT;;SIVIK MARK ROBERT;;BURNS MICHAEL EUGENE;;TAYLOR LUCILLE FLORENCE;;HARDY FREDERICK EDWARD;;BAILLELY GERARD MARCEL ABEL,,https://lens.org/041-753-077-378-620,Granted Patent,no,0,0,13,13,0,C07D223/10;;C07D233/06;;C11D3/3927;;C07D223/10;;C11D3/3927;;C07D233/06,C07D223/10;;C07D233/06;;C11D3/39;;C11D3/395;;C11D7/54,,0,0,,,,EXPIRED
35,AT,T1,AT E196309 T1,024-351-937-755-409,2000-09-15,2000,AT 95927318 T,1995-07-20,US 29890394 A;;US 9509181 W,1994-08-31,"QUATERNÄRE, SUBSTITUIERTE BLEICHAKTIVATOREN","Bleaching compositions, laundry and automatic dishwashing detergent compositions comprising particular quaternary-substituted bleach activators, are provided. More specifically, the invention relates to compositions which provide enhanced cleaning/bleaching benefits though the selection of quaternary-substituted bleach activators having specific leaving groups with a conjugate acid pKa above 13 and with specific ratios of the rate of perhydrolysis to the rate of hydrolysis and the rate of perhydrolysis to the rate of diacylperoxide production. Included are preferred activator compounds and methods for washing fabrics, hard surfaces, and tableware using the activators.",PROCTER & GAMBLE,WILLEY ALAN DAVID;;MIRACLE GREGORY SCOT;;KOTT KEVIN LEE;;BURNS MICHAEL EUGENE;;BAILLELY GERARD MARCEL ABEL;;HARDY FREDERICK EDWARD;;TAYLOR LUCILLE FLORENCE;;SIVIK MARK ROBERT;;GUEDIRA NOUR-EDDINE,,https://lens.org/024-351-937-755-409,Granted Patent,no,0,0,13,13,0,C07D223/10;;C07D233/06;;C11D3/3927;;C07D223/10;;C11D3/3927;;C07D233/06,C07D223/10;;C07D233/06;;C11D3/39;;C11D3/395;;C11D7/54,,0,0,,,,DISCONTINUED
36,EP,B1,EP 0778883 B1,135-967-863-095-435,2000-09-13,2000,EP 95927318 A,1995-07-20,US 9509181 W;;US 29890394 A,1994-08-31,QUARTERNARY SUBSTITUTED BLEACH ACTIVATORS,"Bleaching compositions, laundry and automatic dishwashing detergent compositions comprising particular quaternary-substituted bleach activators, are provided. More specifically, the invention relates to compositions which provide enhanced cleaning/bleaching benefits though the selection of quaternary-substituted bleach activators having specific leaving groups with a conjugate acid pKa above 13 and with specific ratios of the rate of perhydrolysis to the rate of hydrolysis and the rate of perhydrolysis to the rate of diacylperoxide production. Included are preferred activator compounds and methods for washing fabrics, hard surfaces, and tableware using the activators.",PROCTER & GAMBLE,WILLEY ALAN DAVID;;MIRACLE GREGORY SCOT;;KOTT KEVIN LEE;;BURNS MICHAEL EUGENE;;BAILLELY GERARD MARCEL ABEL;;HARDY FREDERICK EDWARD;;TAYLOR LUCILLE FLORENCE;;SIVIK MARK ROBERT;;GUEDIRA NOUR-EDDINE,,https://lens.org/135-967-863-095-435,Granted Patent,yes,1,0,13,13,0,C07D223/10;;C07D233/06;;C11D3/3927;;C07D223/10;;C11D3/3927;;C07D233/06,C07D223/10;;C07D233/06;;C11D3/39;;C11D3/395;;C11D7/54,,0,0,,,,EXPIRED
37,EP,A1,EP 0778883 A1,149-571-427-476-44X,1997-06-18,1997,EP 95927318 A,1995-07-20,US 9509181 W;;US 29890394 A,1994-08-31,QUARTERNARY SUBSTITUTED BLEACH ACTIVATORS,"Bleaching compositions, laundry and automatic dishwashing detergent compositions comprising particular quaternary-substituted bleach activators, are provided. More specifically, the invention relates to compositions which provide enhanced cleaning/bleaching benefits though the selection of quaternary-substituted bleach activators having specific leaving groups with a conjugate acid pKa above 13 and with specific ratios of the rate of perhydrolysis to the rate of hydrolysis and the rate of perhydrolysis to the rate of diacylperoxide production. Included are preferred activator compounds and methods for washing fabrics, hard surfaces, and tableware using the activators.",PROCTER & GAMBLE,WILLEY ALAN DAVID;;MIRACLE GREGORY SCOT;;KOTT KEVIN LEE;;BURNS MICHAEL EUGENE;;BAILLELY GERARD MARCEL ABEL;;HARDY FREDERICK EDWARD;;TAYLOR LUCILLE FLORENCE;;SIVIK MARK ROBERT;;GUEDIRA NOUR-EDDINE,,https://lens.org/149-571-427-476-44X,Patent Application,yes,0,0,13,13,0,C07D223/10;;C07D233/06;;C11D3/3927;;C07D223/10;;C11D3/3927;;C07D233/06,C07D223/10;;C07D233/06;;C11D3/39;;C11D3/395;;C11D7/54,,0,0,,,,EXPIRED
38,US,A,US 5686015 A,184-445-257-460-817,1997-11-11,1997,US 29890394 A,1994-08-31,US 29890394 A,1994-08-31,Quaternary substituted bleach activators,"Bleaching compositions, laundry and automatic dishwashing detergent compositions comprising particular quaternary-substituted bleach activators, are provided. More specifically, the invention relates to compositions which provide enhanced cleaning/bleaching benefits though the selection of quaternary-substituted bleach activators having specific leaving groups with a conjugate acid pKa above 13 and with specific ratios of the rate of perhydrolysis to the rate of hydrolysis and the rate of perhydrolysis to the rate of diacylperoxide production. Included are preferred activator compounds and methods for washing fabrics, hard surfaces, and tableware using the activators.",PROCTER & GAMBLE,WILLEY ALAN DAVID;;MIRACLE GREGORY SCOT;;KOTT KEVIN LEE;;BURNS MICHAEL EUGENE;;BAILLELY GERARD MARCEL ABEL;;GUEDIRA NOUR-EDDINE;;HARDY FREDERICK EDWARD;;TAYLOR LUCILLE FLORENCE;;SIVIK MARK ROBERT,PROCTER & GAMBLE COMPANY THE (1994-10-09);;NORTH CAROLINA STATE UNIVERSITY (2002-08-05),https://lens.org/184-445-257-460-817,Granted Patent,yes,45,83,13,13,0,C07D223/10;;C07D233/06;;C11D3/3927;;C07D223/10;;C11D3/3927;;C07D233/06,C07D223/10;;C07D233/06;;C11D3/39;;C11D3/395;;C11D7/54,252/186.39;;252/186.38;;252/186.33;;252/186.27;;510/312;;510/313;;510/311,0,0,,,,EXPIRED
39,MX,B,MX 351321 B,149-778-769-561-271,2017-09-25,2017,MX 2012014249 A,2012-12-06,MX 2012014249 A,2012-12-06,TOPIC COMPOSITION FOR STIMULATING SALIVATION.,"The present invention is intended to prepare a topic composition in spray as a drug for stimulating salivation, which includes a saliva replacing agent and an anticariogenic agent of topic application in oral mucosa. The composition is useful for treating xerostomia, burning mouth syndrome (SBA), Sjögren syndrome (SS) and periodontal disease, also being used in other transitory, chronic or permanent physiological conditions, in which salivary glands dystrophy is detected, avoiding amongst other conditions, reflux, inadequate absorption of nutrients and infections, such as recurrent candidiasis and suppurative mumps.",UNIV AUTONOMA METROPOLITANA,CARLOS TOMÁS QUIRINO BARREDA;;NORMA ANGÉLICA NOGUÉZ MÉNDEZ;;SUSANA AURORA MACÍN CABRERA;;ALEJANDRO RUBIO MATÍNEZ;;ADALBERTO ABEL MOSQUEDA TAYLOR;;KUAUHYAMA LUNA ORTÍZ;;ERIC ALEJANDRO GARCÍA LÓPEZ;;HILDA LILIA CÁRDENAS RODRÍGUEZ;;CHIHARU MURATA,,https://lens.org/149-778-769-561-271,Granted Patent,no,0,0,2,2,0,,A61K31/4178;;A61K9/12;;A61K47/02;;A61K47/10;;A61K47/36;;A61K47/38;;A61P1/02,,0,0,,,,ACTIVE
40,MX,A,MX 2012014249 A,049-244-681-461-987,2014-06-23,2014,MX 2012014249 A,2012-12-06,MX 2012014249 A,2012-12-06,TOPIC COMPOSITION FOR STIMULATING SALIVATION.,"The present invention is intended to prepare a topic composition in spray as a drug for stimulating salivation, which includes a saliva replacing agent and an anticariogenic agent of topic application in oral mucosa. The composition is useful for treating xerostomia, burning mouth syndrome (SBA), Sjögren syndrome (SS) and periodontal disease, also being used in other transitory, chronic or permanent physiological conditions, in which salivary glands dystrophy is detected, avoiding amongst other conditions, reflux, inadequate absorption of nutrients and infections, such as recurrent candidiasis and suppurative mumps.",UNIV AUTÓNOMA METROPOLITANA,BARREDA CARLOS TOMÁS QUIRINO;;MÉNDEZ NORMA ANGÉLICA NOGUÉZ;;CABRERA SUSANA AURORA MACÍN;;MATÍNEZ ALEJANDRO RUBIO;;TAYLOR ADALBERTO ABEL MOSQUEDA;;ORTÍZ KUAUHYAMA LUNA;;LÓPEZ ERIC ALEJANDRO GARCÍA;;RODRÍGUEZ HILDA LILIA CÁRDENAS;;MURATA CHIHARU,,https://lens.org/049-244-681-461-987,Patent Application,no,0,0,2,2,0,,A61K9/12;;A61K31/00;;A61P1/02,,0,0,,,,ACTIVE
41,JP,A,JP 2008032019 A,121-996-196-252-103,2008-02-14,2008,JP 2007259346 A,2007-10-03,US 53632704 P;;US 54613904 P;;US 93102804 A;;US 93109104 A;;US 93100804 A;;US 93109004 A;;US 93109204 A;;US 93102004 A;;US 93101704 A;;US 93100904 A;;US 93102504 A;;US 93102704 A;;US 93102604 A;;US 93101004 A;;US 93108804 A,2004-01-13,OPERATION METHOD AND DEVICE OF AIRLESS FUEL COMBUSTION BURNER OF EMISSION ABATEMENT ASSEMBLY,"<P>PROBLEM TO BE SOLVED: To remove soot from exhaust gas, by regenerating a particulate filter, by selectively operating a pair of fuel combustion burners. <P>SOLUTION: An emission abatement assembly operation method operates an emission abatement assembly so as to remove the soot from the exhaust gas from an internal combustion engine, and includes a step of determining whether or not the internal combustion engine operates in a predetermined operation state, and a step (S856) of operating the fuel combustion burner so as to regenerate the particulate filter, when the internal combustion engine operates in the predetermined operation state (S854). <P>COPYRIGHT: (C)2008,JPO&INPIT",ARVIN TECHNOLOGIES INC,BERKMAN MERT E;;KINNAIRD EDWARD C;;ABEL JOHN BRIAN;;GOLDSCHMIDT STEPHEN PAUL;;CRANE SAMUEL N JR;;KHADIYA NAVIN;;HUCKABY JON JOSEPH;;TAYLOR WILLIAM III;;CRAWLEY WILBUR H;;JOHNSON RANDALL J;;BIRKBY NICHOLAS;;PEARSON DAVID;;FARR SHOJA;;KONG YOUGEN,,https://lens.org/121-996-196-252-103,Patent Application,no,0,5,19,42,0,F23G7/065;;F01N3/025;;F01N3/0256;;F01N9/00;;F01N11/00;;F01N13/011;;F01N2240/14;;F01N2430/06;;F01N2610/1493;;F01N2900/1811;;F02D41/0235;;F02D41/1448;;F02D41/22;;F02D41/221;;F02D2200/0812;;Y02T10/40,F01N3/02;;B01D46/42;;F01N3/025;;F01N13/04;;F23G7/06,,0,0,,,,PENDING
42,JP,A,JP 2008025588 A,196-272-146-201-612,2008-02-07,2008,JP 2007259345 A,2007-10-03,US 53632704 P;;US 54613904 P;;US 93102804 A;;US 93109104 A;;US 93100804 A;;US 93109004 A;;US 93109204 A;;US 93102004 A;;US 93101704 A;;US 93100904 A;;US 93102504 A;;US 93102704 A;;US 93102604 A;;US 93101004 A;;US 93108804 A,2004-01-13,METHOD AND DEVICE FOR MAKING EXHAUST GAS PASS THROUGH FUEL COMBUSTION BURNER OF EMISSION REDUCING ASSEMBLY,"<P>PROBLEM TO BE SOLVED: To stabilize flame generated by a fuel combustion burner. <P>SOLUTION: This fuel combustion burner operating method for operating the fuel combustion burner of an emission reducing assembly comprises a step of feeding a flow of exhaust gas into a housing of the fuel combustion burner, and a step of parting the flow of the exhaust gas into (i) a combustion flow which is fed through the combustion chamber of the fuel combustion burner and (ii) a bypassing flow which bypasses around the combustion chamber of the fuel combustion burner, and is about 70% or lower of the flow of the exhaust gas. <P>COPYRIGHT: (C)2008,JPO&INPIT",ARVIN TECHNOLOGIES INC,BERKMAN MERT E;;KINNAIRD EDWARD C;;ABEL JOHN BRIAN;;GOLDSCHMIDT STEPHEN PAUL;;CRANE SAMUEL N JR;;KHADIYA NAVIN;;HUCKABY JON JOSEPH;;TAYLOR WILLIAM III;;CRAWLEY WILBUR H;;JOHNSON RANDALL J;;BIRKBY NICHOLAS;;PEARSON DAVID;;FARR SHOJA;;KONG YOUGEN,,https://lens.org/196-272-146-201-612,Patent Application,no,2,10,19,42,0,F23G7/065;;F01N3/025;;F01N3/0256;;F01N9/00;;F01N11/00;;F01N13/011;;F01N2240/14;;F01N2430/06;;F01N2610/1493;;F01N2900/1811;;F02D41/0235;;F02D41/1448;;F02D41/22;;F02D41/221;;F02D2200/0812;;Y02T10/40,F01N3/02;;F01N3/025;;F01N3/20;;F01N13/04;;F23G7/06,,0,0,,,,PENDING
43,WO,A3,WO 2005/070175 A3,041-443-178-128-66X,2006-01-19,2006,US 2005/0000939 W,2005-01-12,US 53632704 P;;US 54613904 P;;US 93102804 A;;US 93109104 A;;US 93100804 A;;US 93109004 A;;US 93109204 A;;US 93102004 A;;US 93101704 A;;US 93100904 A;;US 93102504 A;;US 93102704 A;;US 93102604 A;;US 93101004 A;;US 93108804 A,2004-01-13,EMISSION ABATEMENT ASSEMBLY AND METHOD OF OPERATING THE SAME,An emission abatement assembly (10) includes a first particulate filter (24) having a first fuel-fired burner (20) associated therewith and a second particulate filter (26) having a second fuel-fired burner (22) associated therewith. A control unit (18) controls operation of both the first fuel-fired burner (20) and the second fuel-fired burner (22). A method of operating an emission abatement assembly (10) is also disclosed.,ARVIN TECHNOLOGIES INC;;BERKMAN MERT E;;KINNAIRD EDWARD C;;ABEL JOHN BRIAN;;GOLDSCHMIDT STEPHEN PAUL;;CRANE SAMUEL N JR;;KHADIYA NAVIN;;HUCKABY JON JOSEPH;;TAYLOR WILLIAM III;;CRAWLEY WILBUR H;;JOHNSON RANDALL J;;BIRKBY NICHOLAS;;PEARSON DAVID;;FARR SHOJA;;KONG YOUGEN,BERKMAN MERT E;;KINNAIRD EDWARD C;;ABEL JOHN BRIAN;;GOLDSCHMIDT STEPHEN PAUL;;CRANE SAMUEL N JR;;KHADIYA NAVIN;;HUCKABY JON JOSEPH;;TAYLOR WILLIAM III;;CRAWLEY WILBUR H;;JOHNSON RANDALL J;;BIRKBY NICHOLAS;;PEARSON DAVID;;FARR SHOJA;;KONG YOUGEN,,https://lens.org/041-443-178-128-66X,Search Report,yes,8,0,19,42,0,F23G7/065;;F01N3/025;;F01N3/0256;;F01N9/00;;F01N11/00;;F01N13/011;;F01N2240/14;;F01N2430/06;;F01N2610/1493;;F01N2900/1811;;F02D41/0235;;F02D41/1448;;F02D41/22;;F02D41/221;;F02D2200/0812;;Y02T10/40,F01N3/025;;F01N13/04;;F23G7/06,,1,0,,,See also references of EP 1718389A4,PENDING
44,CN,B,CN 1929895 B,040-730-133-333-729,2011-06-22,2011,CN 200580007276 A,2005-01-12,US 2005/0000939 W;;US 53632704 P;;US 54613904 P;;US 93108804 A;;US 93101004 A;;US 93102604 A;;US 93102704 A;;US 93102504 A;;US 93100904 A;;US 93101704 A;;US 93109204 A,2004-01-13,Emission abatement assembly and method of operating the same,"The invention discloses an emission abatement assembly which removes soot from engine emissions, including a particulate filter, a first fuel-fired burner located on the upstream of the particulate filter, and a control unit configured to control the fuel-fired burner. The control unit includes (i) a processor and (ii) a memory device electrically coupled to the processor. The memory device stores a plurality of instructions. When executed by the processing unit, the instructions allow the processor: to determine whether the engine is operated under a predetermined operation condition or not, and if the engine is operated under the predetermined operation condition, to operate the fuel-fired burner to regenerate the particulate filter. A method of operating an emission abatement assembly is also disclosed.",ARVIN TECHNOLOGIES INC,KINNAIRD EDWARD C;;CRAWLEY WILBUR H;;BERKMAN MERT E;;BRIAN ABEL JOHN;;JOSEPH HUCKABY JON;;PAUL GOLDSCHMIDT STEPHEN;;NAVIN KHADIYA;;JOHNSON RANDALL J;;NICHOLAS BIRKBY;;CRANE SAMUEL N JR;;WILLIAM TAYLOR III;;DAVID PEARSON;;SCHOJA F;;YOUGEN KONG,,https://lens.org/040-730-133-333-729,Granted Patent,no,0,0,2,42,0,,B01D46/00,,0,0,,,,INACTIVE
45,EP,A2,EP 1718389 A2,069-398-077-873-94X,2006-11-08,2006,EP 05705547 A,2005-01-12,US 2005/0000939 W;;US 53632704 P;;US 54613904 P;;US 93102804 A;;US 93109104 A;;US 93100804 A;;US 93109004 A;;US 93109204 A;;US 93102004 A;;US 93101704 A;;US 93100904 A;;US 93102504 A;;US 93102704 A;;US 93102604 A;;US 93101004 A;;US 93108804 A,2004-01-13,EMISSION ABATEMENT ASSEMBLY AND METHOD OF OPERATING THE SAME,,ARVIN TECHNOLOGIES INC,BERKMAN MERT E;;KINNAIRD EDWARD C;;ABEL JOHN BRIAN;;GOLDSCHMIDT STEPHEN PAUL;;CRANE SAMUEL N JR;;KHADIYA NAVIN;;HUCKABY JON JOSEPH;;TAYLOR WILLIAM III;;CRAWLEY WILBUR H;;JOHNSON RANDALL J;;BIRKBY NICHOLAS;;PEARSON DAVID;;FARR SHOJA;;KONG YOUGEN,"ET US HOLDINGS LLC (2007-08-01);;EMCON TECHNOLOGIES LLC (2008-03-19);;FAURECIA EMISSIONS CONTROL TECHNOLOGIES, USA, LLC (2015-12-30)",https://lens.org/069-398-077-873-94X,Patent Application,yes,0,0,19,42,0,F23G7/065;;F01N3/025;;F01N3/0256;;F01N9/00;;F01N11/00;;F01N13/011;;F01N2240/14;;F01N2430/06;;F01N2610/1493;;F01N2900/1811;;F02D41/0235;;F02D41/1448;;F02D41/22;;F02D41/221;;F02D2200/0812;;Y02T10/40,F01N3/025;;F01N9/00;;F01N11/00;;F01N13/04;;F02D41/02;;F02D41/22;;F23G7/06,,0,0,,,,DISCONTINUED
46,WO,A2,WO 2005/070175 A2,180-551-841-277-011,2005-08-04,2005,US 2005/0000939 W,2005-01-12,US 53632704 P;;US 54613904 P;;US 93102804 A;;US 93109104 A;;US 93100804 A;;US 93109004 A;;US 93109204 A;;US 93102004 A;;US 93101704 A;;US 93100904 A;;US 93102504 A;;US 93102704 A;;US 93102604 A;;US 93101004 A;;US 93108804 A,2004-01-13,EMISSION ABATEMENT ASSEMBLY AND METHOD OF OPERATING THE SAME,An emission abatement assembly (10) includes a first particulate filter (24) having a first fuel-fired burner (20) associated therewith and a second particulate filter (26) having a second fuel-fired burner (22) associated therewith. A control unit (18) controls operation of both the first fuel-fired burner (20) and the second fuel-fired burner (22). A method of operating an emission abatement assembly (10) is also disclosed.,ARVIN TECHNOLOGIES INC;;BERKMAN MERT E;;KINNAIRD EDWARD C;;ABEL JOHN BRIAN;;GOLDSCHMIDT STEPHEN PAUL;;CRANE SAMUEL N JR;;KHADIYA NAVIN;;HUCKABY JON JOSEPH;;TAYLOR WILLIAM III;;CRAWLEY WILBUR H;;JOHNSON RANDALL J;;BIRKBY NICHOLAS;;PEARSON DAVID;;FARR SHOJA;;KONG YOUGEN,BERKMAN MERT E;;KINNAIRD EDWARD C;;ABEL JOHN BRIAN;;GOLDSCHMIDT STEPHEN PAUL;;CRANE SAMUEL N JR;;KHADIYA NAVIN;;HUCKABY JON JOSEPH;;TAYLOR WILLIAM III;;CRAWLEY WILBUR H;;JOHNSON RANDALL J;;BIRKBY NICHOLAS;;PEARSON DAVID;;FARR SHOJA;;KONG YOUGEN,,https://lens.org/180-551-841-277-011,Patent Application,yes,0,22,19,42,0,F23G7/065;;F01N3/025;;F01N3/0256;;F01N9/00;;F01N11/00;;F01N13/011;;F01N2240/14;;F01N2430/06;;F01N2610/1493;;F01N2900/1811;;F02D41/0235;;F02D41/1448;;F02D41/22;;F02D41/221;;F02D2200/0812;;Y02T10/40,F01N3/025;;F01N13/04;;F23G7/06,,1,0,,,See references of EP 1718389A4,PENDING
47,JP,A,JP 2013068225 A,188-784-692-953-917,2013-04-18,2013,JP 2012276997 A,2012-12-19,US 53632704 P;;US 54613904 P;;US 93102804 A;;US 93109104 A;;US 93100804 A;;US 93109004 A;;US 93109204 A;;US 93102004 A;;US 93101704 A;;US 93100904 A;;US 93102504 A;;US 93102704 A;;US 93102604 A;;US 93101004 A;;US 93108804 A,2004-01-13,METHOD AND APPARATUS FOR CONTROLLING FUEL-FIRED BURNER OF EMISSION ABATEMENT ASSEMBLY,"PROBLEM TO BE SOLVED: To monitor operation of a fuel-fired burner.SOLUTION: A method of operating a control unit of an emission abatement assembly includes the steps of: monitoring operation of a fuel-fired burner of the emission abatement assembly and determining if predetermined conditions are present, generating an error signal if the predetermined conditions are present, and communicating the error signal to an engine control unit of an engine.",FAURECIA EMISSIONS CONTROL TECHNOLOGIES USA LLC,BERKMAN MERT E;;KINNAIRD EDWARD C;;ABEL JOHN BRIAN;;GOLDSCHMIDT STEPHEN PAUL;;CRANE SAMUEL N JR;;KHADIYA NAVIN;;HUCKABY JON JOSEPH;;TAYLOR WILLIAM III;;CRAWLEY WILBUR H;;JOHNSON RANDALL J;;BIRKBY NICHOLAS;;PEARSON DAVID;;FARR SHOJA;;KONG YOUGEN,,https://lens.org/188-784-692-953-917,Patent Application,no,17,2,19,42,0,F23G7/065;;F01N3/025;;F01N3/0256;;F01N9/00;;F01N11/00;;F01N13/011;;F01N2240/14;;F01N2430/06;;F01N2610/1493;;F01N2900/1811;;F02D41/0235;;F02D41/1448;;F02D41/22;;F02D41/221;;F02D2200/0812;;Y02T10/40,F02D41/04;;F01N3/025;;F01N13/04;;F23G7/06,,0,0,,,,INACTIVE
48,EP,A4,EP 1718389 A4,144-772-621-667-468,2012-05-09,2012,EP 05705547 A,2005-01-12,US 2005/0000939 W;;US 53632704 P;;US 54613904 P;;US 93102804 A;;US 93109104 A;;US 93100804 A;;US 93109004 A;;US 93109204 A;;US 93102004 A;;US 93101704 A;;US 93100904 A;;US 93102504 A;;US 93102704 A;;US 93102604 A;;US 93101004 A;;US 93108804 A,2004-01-13,EMISSION ABATEMENT ASSEMBLY AND METHOD OF OPERATING THE SAME,,EMCON TECHNOLOGIES LLC,BERKMAN MERT E;;KINNAIRD EDWARD C;;ABEL JOHN BRIAN;;GOLDSCHMIDT STEPHEN PAUL;;CRANE SAMUEL N JR;;KHADIYA NAVIN;;HUCKABY JON JOSEPH;;TAYLOR WILLIAM III;;CRAWLEY WILBUR H;;JOHNSON RANDALL J;;BIRKBY NICHOLAS;;PEARSON DAVID;;FARR SHOJA;;KONG YOUGEN,"ET US HOLDINGS LLC (2007-08-01);;EMCON TECHNOLOGIES LLC (2008-03-19);;FAURECIA EMISSIONS CONTROL TECHNOLOGIES, USA, LLC (2015-12-30)",https://lens.org/144-772-621-667-468,Search Report,no,5,0,19,42,0,F01N3/025;;F01N3/0256;;F01N9/00;;F01N11/00;;F01N2240/14;;F01N2430/06;;F01N2610/1493;;F01N2900/1811;;F02D41/0235;;F02D41/1448;;F02D41/22;;F02D41/221;;F02D2200/0812;;F23G7/065;;F01N13/011;;Y02T10/40,F01N3/025;;F01N9/00;;F01N11/00;;F01N13/04;;F02D41/02;;F02D41/22;;F23G7/06,,0,0,,,,DISCONTINUED
49,JP,A,JP 2008032018 A,118-484-032-293-569,2008-02-14,2008,JP 2007259344 A,2007-10-03,US 53632704 P;;US 54613904 P;;US 93102804 A;;US 93109104 A;;US 93100804 A;;US 93109004 A;;US 93109204 A;;US 93102004 A;;US 93101704 A;;US 93100904 A;;US 93102504 A;;US 93102704 A;;US 93102604 A;;US 93101004 A;;US 93108804 A,2004-01-13,CONTROL METHOD AND DEVICE OF FUEL COMBUSTION BURNER OF EMISSION ABATEMENT ASSEMBLY,"<P>PROBLEM TO BE SOLVED: To monitor operation of a fuel combustion burner capable of adjusting a fuel quantity supplied to a burner based on a heating temperature, by confirming the heating temperature of the burner. <P>SOLUTION: An operation method of a control unit of an emission abatement assembly, includes a step of determining whether or not to be in a predetermined state by monitoring operation of the fuel combustion burner of the emission abatement assembly, a step (S308) of generating an error signal when put in the predetermined state, and a step (S310) of transmitting the error signal to an engine control unit of an engine. <P>COPYRIGHT: (C)2008,JPO&INPIT",ARVIN TECHNOLOGIES INC,BERKMAN MERT E;;KINNAIRD EDWARD C;;ABEL JOHN BRIAN;;GOLDSCHMIDT STEPHEN PAUL;;CRANE SAMUEL N JR;;KHADIYA NAVIN;;HUCKABY JON JOSEPH;;TAYLOR WILLIAM III;;CRAWLEY WILBUR H;;JOHNSON RANDALL J;;BIRKBY NICHOLAS;;PEARSON DAVID;;FARR SHOJA;;KONG YOUGEN,,https://lens.org/118-484-032-293-569,Patent Application,no,2,0,19,42,0,F23G7/065;;F01N3/025;;F01N3/0256;;F01N9/00;;F01N11/00;;F01N13/011;;F01N2240/14;;F01N2430/06;;F01N2610/1493;;F01N2900/1811;;F02D41/0235;;F02D41/1448;;F02D41/22;;F02D41/221;;F02D2200/0812;;Y02T10/40,F01N3/02;;F01N3/025;;F01N3/18;;F01N13/04;;F02D43/00;;F02D45/00;;F23G7/06,,0,0,,,,INACTIVE
